---
figid: PMC4066235__fig-3
figlink: /pmc/articles/PMC4066235/figure/f3/
number: F3
caption: PI3K/AKT and MAPK signal transduction pathway activation in response to IR.
  IR activates the EGFR family of RTKs, which triggers both PI3K/AKT and MAPK signaling.
  On the left, activation of RAS by the RTK leads to activation of RAF-1. Active RAF-1
  initiates a cascade of phosphorylation-dependent activation, first of MEK1/2 followed
  by ERK1/2. ERK1/2 activation results in the activation of p90rsk, which promotes
  the transcription of anti-apoptotic factors, including miRNAs such as miR-21. Importantly,
  miR-21 targets PTEN, which inhibits the PI3K/AKT pathway, promoting PI3K/AKT signaling.
  On the right, the RTK activates PI3K, which, in turn, phosphorylates AKT. Activated
  AKT promotes the transcription of anti-apoptotic factors and inhibits the transcription
  of pro-apoptotic factors. miRNA regulation of the FOXO proteins is shown. Other
  members of the apoptotic pathway will be discussed later in . miRNA regulation is
  extensive in both these pathways. miRNAs that have been bolded indicate miRNAs which
  have multiple targets in the same pathway. Additional underlining identifies miRNAs
  that are involved in almost every pathway of the DDR. Dotted arrow indicates potential
  for a positive feedback loop. ERK1/2, extracellular signal-regulated kinase 1/2;
  MAPK, mitogen-activated protein kinase; MEK1/2, MAPK kinase 1/2; PI3K, phosphoinositide
  3-kinase; PTEN, phosphatase and tensin homolog; RAS; RTK, receptor tyrosine kinase.
pmcid: PMC4066235
papertitle: microRNAs in Cancer Cell Response to Ionizing Radiation.
reftext: Jennifer R. Czochor, et al. Antioxid Redox Signal. 2014 Jul 10;21(2):293-312.
pmc_ranked_result_index: '3125'
pathway_score: 0.9512495
filename: fig-3.jpg
figtitle: microRNAs in Cancer Cell Response to Ionizing Radiation
year: '2014'
organisms: Homo sapiens
ndex: f35cb5e5-def3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4066235__fig-3.html
  '@type': Dataset
  description: PI3K/AKT and MAPK signal transduction pathway activation in response
    to IR. IR activates the EGFR family of RTKs, which triggers both PI3K/AKT and
    MAPK signaling. On the left, activation of RAS by the RTK leads to activation
    of RAF-1. Active RAF-1 initiates a cascade of phosphorylation-dependent activation,
    first of MEK1/2 followed by ERK1/2. ERK1/2 activation results in the activation
    of p90rsk, which promotes the transcription of anti-apoptotic factors, including
    miRNAs such as miR-21. Importantly, miR-21 targets PTEN, which inhibits the PI3K/AKT
    pathway, promoting PI3K/AKT signaling. On the right, the RTK activates PI3K, which,
    in turn, phosphorylates AKT. Activated AKT promotes the transcription of anti-apoptotic
    factors and inhibits the transcription of pro-apoptotic factors. miRNA regulation
    of the FOXO proteins is shown. Other members of the apoptotic pathway will be
    discussed later in . miRNA regulation is extensive in both these pathways. miRNAs
    that have been bolded indicate miRNAs which have multiple targets in the same
    pathway. Additional underlining identifies miRNAs that are involved in almost
    every pathway of the DDR. Dotted arrow indicates potential for a positive feedback
    loop. ERK1/2, extracellular signal-regulated kinase 1/2; MAPK, mitogen-activated
    protein kinase; MEK1/2, MAPK kinase 1/2; PI3K, phosphoinositide 3-kinase; PTEN,
    phosphatase and tensin homolog; RAS; RTK, receptor tyrosine kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R6
  - BCL2
  - AKT1
  - AKT2
  - BAX
  - PIK3R5
  - RAF1
  - AKT3
  - RPS6KA5
  - FOXO4
  - PIK3R4
  - PIK3CG
  - FOXO3
  - HRAS
  - PIK3CD
  - BCL2L11
  - EGFR
  - RPS6KA6
  - MAPK3
  - MAPK1
  - FOXO6
  - PIK3CA
  - PIK3CB
  - MAP2K1
  - RPS6KA3
  - PTEN
  - MCL1
  - PDK1
  - RPS6KA2
  - RPS6KA4
  - PIK3R3
  - FOXO1
  - RPS6KA1
  - KRAS
  - NRAS
  - MAP2K2
  - LILRB1
  - Cancer
  - Lung cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: BAX
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAF-1
  symbol: Raf-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: p90rsk
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: BIM
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: p90rsk
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: ERK1
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MEK1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: p90rsk
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: MCL1
  symbol: MCL1
  source: hgnc_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: p90rsk
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: p90rsk
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: p90rsk
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: K-RAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: miR-7
  symbol: MIR-7
  source: hgnc_alias_symbol
  hgnc_symbol: LILRB1
  entrez: '10859'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC4066235__F3
redirect_from: /figures/PMC4066235__F3
figtype: Figure
---
